State Street Corp Has $22.81 Million Stock Position in MiMedx Group, Inc. (NASDAQ:MDXG)

State Street Corp lowered its stake in MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 2.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,860,148 shares of the company's stock after selling 107,819 shares during the quarter. State Street Corp owned approximately 2.63% of MiMedx Group worth $22,813,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of MDXG. Harbor Capital Advisors Inc. grew its holdings in shares of MiMedx Group by 299.9% during the third quarter. Harbor Capital Advisors Inc. now owns 1,027,738 shares of the company's stock valued at $6,074,000 after buying an additional 770,744 shares in the last quarter. Millennium Management LLC boosted its position in MiMedx Group by 339.9% during the 2nd quarter. Millennium Management LLC now owns 889,446 shares of the company's stock worth $6,164,000 after acquiring an additional 687,267 shares during the period. Dimensional Fund Advisors LP grew its stake in MiMedx Group by 47.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,292,822 shares of the company's stock valued at $8,958,000 after acquiring an additional 413,443 shares in the last quarter. Paradigm Capital Management Inc. NY increased its holdings in shares of MiMedx Group by 6.6% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 4,167,200 shares of the company's stock valued at $28,879,000 after purchasing an additional 258,700 shares during the period. Finally, Los Angeles Capital Management LLC purchased a new stake in shares of MiMedx Group in the second quarter worth approximately $988,000. Institutional investors and hedge funds own 79.15% of the company's stock.

MiMedx Group Stock Up 1.9 %

Shares of MiMedx Group stock traded up $0.17 during trading on Monday, hitting $9.27. 462,465 shares of the stock traded hands, compared to its average volume of 752,984. The stock has a market cap of $1.36 billion, a P/E ratio of 16.85 and a beta of 1.98. The company has a fifty day moving average price of $8.01 and a two-hundred day moving average price of $7.09. MiMedx Group, Inc. has a twelve month low of $5.47 and a twelve month high of $10.14. The company has a debt-to-equity ratio of 0.10, a quick ratio of 3.53 and a current ratio of 4.10.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered shares of MiMedx Group from a "strong-buy" rating to a "buy" rating in a research note on Friday, November 8th. Six equities research analysts have rated the stock with a buy rating, According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $12.00.

MiMedx Group Company Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins.